DNA’s year started strongly – net sales and operating result grew in the first quarter

Unless otherwise stated, the comparison figures in brackets refer to the corresponding period in the previous year (reference period). Figures are unaudited.

January–March 2017

  • Net sales increased 5.7% and amounted to EUR 213.4 million (202.0 million).
  • EBITDA increased 9.7% to EUR 65.9 million (60.1 million) or 30.9% (29.8%) of net sales.
  • The operating result increased 14.9% and was EUR 28.9 million (25.1 million) or 13.5% (12.4%) of net sales.
  • The mobile communication subscription base grew 3.8%, totalling 2,732,000 (2,632,000).
  • Revenue per user (ARPU) for mobile communications amounted to EUR 17.8 (16.4).
  • The mobile communication subscription turnover rate (CHURN) was 21.0% (13.6%).
  • The fixed-network subscription base (voice, broadband and cable television) grew slightly and was 1,120,000 subscriptions at the end of March (1,112,000).

DNA’s outlook for 2017 remains unchanged

DNA’s net sales are expected to remain at the same level and the comparable operating result is expected to improve somewhat in 2017 compared to 2016. The Group’s financial position and liquidity is expected to remain at a healthy level.

Key figures


Figures are unaudited.







EUR million 1-3/2017 1-3/2016 Change, % 1-12/2016
Net sales 213.4 202.0 5.7% 858.9
EBITDA 65.9 60.1 9.7% 236.3
- % of net sales 30.9% 29.8%
27.5%
Comparable EBITDA * 65.9 60.1 9.7% 247.1
- % of net sales 30.9% 29.8%
28.8%
Depreciation, amortisation and impairment 37.1 35.0
145.0
Operating result, EBIT 28.9 25.1 14.9% 91.2
- % of net sales 13.5% 12.4%
10.6%
Comparable operating result* 28.9 25.1 14.9% 102.1
- % of net sales 13.5% 12.4%
11.9%
Net result before tax 26.6 22.7 17.2% 81.7
Net result for the period 21.2 18.2 16.7% 65.2
Return on investment (ROI), % 12.5 10.7
9.6
Return on equity (ROE), % 14.9 14.1
11.6
Capital expenditure 21.2 20.8 1.8% 143.6
Cash flow after investing activities 10.3 29.1
83.5
Net debt, EUR million 314.3 383.4
321.7
Net debt/EBITDA 1.19 1.59
1.36
Net gearing, % 57.6 76.2
53.9
Equity ratio, % 45.3 42.6
48.4
Basic earnings per share, EUR 0.16 0.14
0.51
Diluted earnings per share, EUR 0.16 0.14
0.51
Personnel at the end of period 1,684 1,683
1,668
*Group key figures





Additional information:

Jukka Leinonen, CEO, DNA Plc, tel. +358 44 044 1000, jukka.leinonen(at)dna.fi
Timo Karppinen, CFO, DNA Plc, tel. +358 44 044 5007, timo.karppinen(at)dna.fi
Marja Mäkinen, Head of IR, DNA Plc, tel. +358 44 044 1262, marja.makinen(at)dna.fi
DNA Corporate Communications, tel. +358 44 044 8000, viestinta(at)dna.fi

DNA’s financial publications in 2017:

• Half Year Financial Report, 18 July 2017 at 8:30 AM
• Interim Report January-September, 20 October 2017 at 8:30 AM

Distribution:
Nasdaq Helsinki
Key media
www.dna.fi